0001181431-14-029265.txt : 20140814 0001181431-14-029265.hdr.sgml : 20140814 20140814200008 ACCESSION NUMBER: 0001181431-14-029265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140813 FILED AS OF DATE: 20140814 DATE AS OF CHANGE: 20140814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seely Lynn CENTRAL INDEX KEY: 0001327111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 141044831 MAIL ADDRESS: STREET 1: 501 2ND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 rrd414618.xml SEELY -- 8/13/14 EXERCISE AND SALE X0306 4 2014-08-13 0 0001011835 MEDIVATION, INC. MDVN 0001327111 Seely Lynn C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Medical Officer Common Stock 2014-08-13 4 M 0 12500 9.385 A 71522 D Common Stock 2014-08-13 4 M 0 7500 6.735 A 79022 D Common Stock 2014-08-13 4 S 0 11000 83.12 D 68022 D Common Stock 2014-08-13 4 S 0 5700 84.01 D 62322 D Common Stock 2014-08-13 4 S 0 3300 84.63 D 59022 D Stock Option (Right to Buy) 9.385 2014-08-13 4 M 0 12500 0.00 D 2018-10-31 Common Stock 12500 20000 D Stock Option (Right to Buy) 6.735 2014-08-13 4 M 0 7500 0.00 D 2020-12-15 Common Stock 7500 45000 D Shares sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $82.70 to $83.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $83.75 to $84.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $84.52 to $84.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. The shares subject to the option shall become vested in according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on December 15, 2011, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) vest on the first day of each month thereafter. /s/ Jennifer Rhodes, Attorney-in-fact 2014-08-14